Puma Biotechnology | PBYI - 負債

株価
7.78
毎日の変更
-0.02 -0.26%
毎月
29.67%
毎年
175.89%
Q2 予測
7.57




負債 変化する 日付
Agios Pharmaceuticals USD 44.52M 4.24M 2025-09
Alnylam Pharmaceuticals USD 1.31B 11.39M 2025-09
Amgen USD 54.59B 1.62B 2025-09
Biogen USD 6.29B 1.7M 2025-12
BioMarin Pharmaceutical USD 604.24M 375K 2025-09
Daiichi Sankyo JPY 201.14B 99.81B 2025-09
Esperion Therapeutics USD 262.92M 1.76M 2024-09
Exelixis USD 176.46M 3.38M 2025-09
Gilead Sciences USD 24.94B 5M 2025-09
Glaxosmithkline GBP 17.75B 396M 2025-09
Incyte USD 40.41M 855K 2025-12
MacroGenics USD 37.01M 238K 2025-09
Moderna USD 734M 7M 2025-09
Novartis USD 32.64B 1.37B 2025-06
Pfizer USD 60.85B 78M 2025-09
PTC Therapeutics USD 286.32M 306K 2025-09
Puma Biotechnology USD 89.06M 55.07M 2024-06
Regeneron Pharmaceuticals USD 2.71B 400K 2025-09
Roche Holding CHF 33.03B 1.41B 2025-06
Sangamo BioSciences USD 0 0 2022-06
Sarepta Therapeutics USD 1.25B 103.69M 2025-09
Takeda JPY 4.85T 208B 2025-12
TG Therapeutics USD 245.34M 8.38M 2025-09
Ultragenyx Pharmaceutical USD 33.83M 2.46M 2025-09
Vanda Pharmaceuticals USD 4.96M 4.96M 2024-12
Vertex Pharmaceuticals USD 1.83B 307.4M 2025-09